These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3000299

  • 1. [A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration].
    Furuse K.
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2352-7. PubMed ID: 3000299
    [Abstract] [Full Text] [Related]

  • 2. [A phase II study of NK171 (etoposide)].
    Kimura K, Niitani H.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [Abstract] [Full Text] [Related]

  • 3. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
    Konno K, Nagahama F, Nakai Y, Nakabayashi T, Hiraga Y, Takebe K, Tamura M, Oizumi K, Sato M, Ito T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671
    [Abstract] [Full Text] [Related]

  • 4. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y, Ohshima S, Kado M, Nakayama M, Shimokata K, Sakai S, Ito F, Chikata E, Hara K, Kanda T.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [Abstract] [Full Text] [Related]

  • 5. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
    Kado M, Oshima S, Matsui Y, Shimokata K, Hara K, Kanda T, Shima K, Takenaka S.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
    [Abstract] [Full Text] [Related]

  • 6. [Phase I clinical study of NK 171 (etoposide)].
    Kimura K, Yamada K, Niitani H.
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):851-6. PubMed ID: 2985006
    [Abstract] [Full Text] [Related]

  • 7. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 8. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
    Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
    [Abstract] [Full Text] [Related]

  • 9. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
    Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P.
    Cancer; 2002 Oct 01; 95(7):1511-9. PubMed ID: 12237920
    [Abstract] [Full Text] [Related]

  • 10. [Effects of oral etoposide in small cell carcinoma of the lung].
    Miyamoto H, Ito M, Araya Y, Takaoka K, Isobe H, Dosaka H, Kawakami Y, Shimizu T, Onodera S.
    Gan To Kagaku Ryoho; 1984 Jun 01; 11(6):1244-7. PubMed ID: 6329103
    [Abstract] [Full Text] [Related]

  • 11. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
    Yoshida T, Nakanishi J, Ito K, Kobayashi S, Ohtake S, Nakamura S, Hattori K.
    Gan To Kagaku Ryoho; 1984 Aug 01; 11(8):1579-84. PubMed ID: 6476835
    [Abstract] [Full Text] [Related]

  • 12. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
    Miller AA, Rosner GL, Ratain MJ, Hollis DR, Green MR, Schilsky RL.
    Clin Cancer Res; 1997 May 01; 3(5):719-25. PubMed ID: 9815741
    [Abstract] [Full Text] [Related]

  • 13. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
    Kimura K, Yamada K, Yoshida T.
    Gan To Kagaku Ryoho; 1986 Mar 01; 13(3 Pt 1):496-501. PubMed ID: 3954373
    [Abstract] [Full Text] [Related]

  • 14. Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.
    Eckardt JR, von Pawel J, Papai Z, Tomova A, Tzekova V, Crofts TE, Brannon S, Wissel P, Ross G.
    J Clin Oncol; 2006 May 01; 24(13):2044-51. PubMed ID: 16648504
    [Abstract] [Full Text] [Related]

  • 15. [A phase II study of carboplatin in small cell lung cancer].
    Komatsu H, Furuse K, Nishikawa H, Minoda S, Saotome K, Nemoto E, Tani Y, Saito T, Ishiwata K, Tsutsumi M.
    Gan To Kagaku Ryoho; 1988 Aug 01; 15(8):2313-8. PubMed ID: 2841905
    [Abstract] [Full Text] [Related]

  • 16. [A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
    Wakui A, Yokoyama M, Takahashi H, Yoshida Y, Sakata Y, Sato S, Kano A, Kawamoto K, Hashimoto S, Konno K.
    Gan To Kagaku Ryoho; 1986 Feb 01; 13(2):319-29. PubMed ID: 3947109
    [Abstract] [Full Text] [Related]

  • 17. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Konishi I, Kitani T, Nagai K, Kanamaru A, Kohsaki M, Masaoka T, Shibata H, Horiuchi A, Tsubaki K, Kawagoe H.
    Gan To Kagaku Ryoho; 1985 Jul 01; 12(7):1482-6. PubMed ID: 4015122
    [Abstract] [Full Text] [Related]

  • 18. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
    Bunn PA, Kelly K.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 20. Etoposide by oral route in the treatment of unresectable non-small cell lung cancer.
    Scagliotti G, Lodico D, Gozzelino F, Pescetti G.
    Chemioterapia; 1984 Oct 01; 3(5):324-6. PubMed ID: 6532545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.